Skip to main content
. 2019 Jul 29;17:86. doi: 10.1186/s12964-019-0393-8

Fig. 5.

Fig. 5

Western blot analyses of HDAC1 expression in HL-60, HL-60/ADM, K562, K562/A02, and BMCs of refractory AML and remission AML 2, 4, and 6 h after CHX treatment. Data are the mean ± SD of three independent experiments in AML cells. **P < 0.01 vs. HL-60/ADM or K562/A02 or refractory BMCs